Literature DB >> 14472423

Studies in molecular pathology. I. Localization and pathogenic role of heterologous immune complexes.

R C MELLORS, W J BRZOSKO.   

Abstract

After intravenous injection in mice, rabbit immune complexes, solubilized in antigen excess and containing fluorescent antigens (BSA* or OA*) or fluorescent antibody, or both, were promptly localized in reticuloendothelial cells, and polymorphonuclear leukocytes, of the sinusoids of liver and the red pulp of spleen; in glomeruli and elsewhere in kidney; in capillary endothelium of heart and lung; and in hepatic cells. Thereafter manifold processes occurred. Within 48 hours the immune complexes were scarcely detectable in liver and splenic red pulp but now were localized in the germinal centers of white pulp where heretofore they had been seen only in trace amounts. This new localization presumably was associated with the antibody-forming activity of the germinal centers, for the immune phase of antigen clearance from the blood had already begun. Although the immune complexes were localized in various regions of the nephrons and their appertaining blood vessels, the initial sites of predilection were the glomerular capillary walls and intercapillary spaces. After 48 hours the immune complexes were still detectable, although in diminished amounts, in the glomeruli but had by now essentially disappeared from other renal sites. The localization of immune complexes in the kidney was associated with proteinuria and with structural changes which closely simulated in some instances those of human membranous glomerulonephritis, of focal and diffuse types, and consisted mainly of eosinophilic swellings of the glomerular capillary walls, intercapillary spaces, and basement membranes. There was a close correspondence between the distributions of the eosinophilic swellings and the fluorescent immune complexes. The renal localization and persistence of fluorescent antigens (BSA* or OA*), after separate injections in mice, differed from that of fluorescent immune complexes in several respects. For example BSA* showed predilection for the glomerular basement membranes and was localized sparsely in the capillary walls and intercapillary spaces; OA* was localized only in minute amounts; and neither was detectable in more than trace amounts at 48 hours after injection. These fluorescent proteins (of low molecular weights, 40,000, 70,000) did not cause glomerulonephritis within the time interval studied, whereas fluorescent immune complexes, containing on the average two molecules of antigen to one of antibody (with minimum molecular weights of 240,000 to 300,000) produced glomerulonephritis in some instances, in confirmation of the observations of others. Since the localization of the immune complexes occurred immediately and without known immunologic relation to the kidney itself, the selective physical retention of proteins by structures comprising the glomerular ultrafilters appeared to be of pathogenic significance in this form of membranous glomerulonephritis in mice, as perhaps also in nephrotic glomerulonephritis in man. If after injection of fluorescent immune complex, homologous antiserum was also administered intravenously so as to produce acute anaphylactic death, coarse and occlusive depositions of immune precipitates occurred in pulmonary, myocardial, and renal capillaries, and in hepatic sinusoids.

Entities:  

Keywords:  KIDNEY/pathology; LIVER/pathology; RETICULOENDOTHELIAL SYSTEM/pathology; SERUM SICKNESS/experimental; SPLEEN/pathology

Mesh:

Substances:

Year:  1962        PMID: 14472423      PMCID: PMC2137538          DOI: 10.1084/jem.115.5.891

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Localization of colloidal substances in vascular endothelium: a mechanism of tissue damage. I. Factors causing the pathologic deposition of colloidal carbon.

Authors:  B BENACERRAF; R T McCLUSKEY; D PATRAS
Journal:  Am J Pathol       Date:  1959 Jan-Feb       Impact factor: 4.307

2.  Fluorescent protein tracers; a trial of new fluorochromes and the development of an alternative to fluorescein.

Authors:  C S CHADWICK; M G McENTEGART; R C NAIRN
Journal:  Immunology       Date:  1958-10       Impact factor: 7.397

3.  Isothiocyanate compounds as fluorescent labeling agents for immune serum.

Authors:  J L RIGGS; R J SEIWALD; J H BURCKHALTER; C M DOWNS; T G METCALF
Journal:  Am J Pathol       Date:  1958 Nov-Dec       Impact factor: 4.307

4.  An immunohistologic study on the occurrence of intravascular antigen-antibody precipitation and its role in anaphylaxis in the rabbit.

Authors:  G E McKINNON; E C ANDREWS; R H HEPTINSTALL; F G GERMUTH
Journal:  Bull Johns Hopkins Hosp       Date:  1957-11

5.  Elimination of antigen-antibody complexes from sera of rabbits.

Authors:  W O WEIGLE
Journal:  J Immunol       Date:  1958-09       Impact factor: 5.422

6.  The production of lesions of serum sickness in normal animals by the passive transfer of antibody in the presence of antigen.

Authors:  F G GERMUTH; A D POLLACK
Journal:  Bull Johns Hopkins Hosp       Date:  1958-05

7.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

8.  A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type.

Authors:  F G GERMUTH
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

9.  Cellular sites of formation of gamma globulin.

Authors:  L G ORTEGA; R C MELLORS
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307

10.  Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction.

Authors:  R C MELLORS; L G ORTEGA; H R HOLMAN
Journal:  J Exp Med       Date:  1957-08-01       Impact factor: 14.307

View more
  12 in total

1.  Immune complex infusion in the rat. Renal functional and morphological changes.

Authors:  S O'Regan; M Smith; K N Drummond
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

Review 2.  Follicular dendritic cells: dynamic antigen libraries.

Authors:  Balthasar A Heesters; Riley C Myers; Michael C Carroll
Journal:  Nat Rev Immunol       Date:  2014-06-20       Impact factor: 53.106

3.  The primary immune response in mice. 3. Retention of sheep red blood cell immunogens by the spleen and liver.

Authors:  R E Franzl
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

4.  The role of the mesangial cell in proliferative glomerulonephritis.

Authors:  A M Davison; D Thomson; M K MacDonald; W S Uttley; J S Robson
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

5.  Localization of 125-I-labelled antigen in germinal centres of mouse spleen: effects of competitive injection of specific or non-cross-reacting antigen.

Authors:  M G Hanna; M W Francis; L C Peters
Journal:  Immunology       Date:  1968-07       Impact factor: 7.397

6.  Affinity of antigen for white cells and its relation to the induction of antibody formation.

Authors:  D Sulitzeanu
Journal:  Bacteriol Rev       Date:  1968-12

7.  Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice.

Authors:  G R Gallo; T Caulin-Glaser; M E Lamm
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

8.  Studies of the pathogenetic role of humoral antibodies reacting with subcellular organ antigens. I. Active immunization of rabbits with rat-organ antigens.

Authors:  G Dóbiás; M Balázs
Journal:  Immunology       Date:  1967-04       Impact factor: 7.397

9.  Aggravation of hepatic lesions in mice by in vivo localization of immune complexes (Auer hepatitis).

Authors:  F Paronetto; H Popper
Journal:  Am J Pathol       Date:  1965-10       Impact factor: 4.307

10.  Electron microscopic studies of human glomerulonephritis with ferritin-conjugated antibody. Localization of antigen-antibody complexes in glomerular structures of patients with acute glomerulonephritis.

Authors:  G A Andres; L Accinni; K C Hsu; J B Zabriskie; B C Seegal
Journal:  J Exp Med       Date:  1966-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.